CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Piracetam

吡拉西坦 杂质对照品Piracetam Impurities

EP41 个杂质条目41 impurity entries

本页汇总 吡拉西坦 的 41 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 41 impurity reference standards of Piracetam with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 吡拉西坦(Piracetam)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesStability-Indicating TLC-Densitometric and HPLC Methods for the Simultaneous Determination of Piracetam and Vincamine in the Presence of Their Degradation Products
    Journal of AOAC International · 2016 · Ahmed AB et al.  ·  PMID 27569579  ·  DOI
  2. 杂质研究Impurity studiesSimultaneous determination of piracetam and its four impurities by RP-HPLC with UV detection
    Journal of chromatographic science · 2010 · Arayne MS et al.  ·  PMID 20819285  ·  DOI
  3. 杂质研究Impurity studiesDevelopment and validation of stability indicating chromatographic methods for simultaneous determination of citicoline and piracetam
    Journal of separation science · 2020 · Abdelrahman MM et al.  ·  PMID 32431004  ·  DOI
  4. 分析方法Analytical MethodsDevelopment and validation of spectrophotometric methods for simultaneous estimation of citicoline and piracetam in tablet dosage form
    Journal of pharmacy & bioallied sciences · 2013 · Sivadas A et al.  ·  PMID 24082696  ·  DOI
  5. 分析方法Analytical MethodsA new green approach for the reduction of consumed solvents and simultaneous quality control analysis of several pharmaceuticals using a fast and economic RP-HPLC method; a case study for a mixture of piracetam, ketoprofen and omeprazole drugs
    RSC advances · 2022 · Abdelgawad MA et al.  ·  PMID 35733689  ·  DOI

吡拉西坦 —— 原料药与杂质对照品Piracetam — drug substance & impurities

共 41 个条目(含原料药本体)41 items incl. the drug substance
Piracetam Impurity 2 (Piracetam EP Impurity B) structure
EPB
吡拉西坦杂质2 (吡拉西坦EP杂质B)Piracetam Impurity 2 (Piracetam EP Impurity B)
Piracetam Impurity 2 (Piracetam EP Impurity B)
CAS No.59776-88-4
Chemical FormulaC7H11NO3
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 3 (Piracetam EP Impurity C) structure
EPC
吡拉西坦杂质3 (吡拉西坦EP杂质C)Piracetam Impurity 3 (Piracetam EP Impurity C)
Piracetam Impurity 3 (Piracetam EP Impurity C)
CAS No.61516-73-2
Chemical FormulaC8H13NO3
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 4(Piracetam EP Impurity D) structure
EPD
吡拉西坦杂质4(吡拉西坦EP杂质D)Piracetam Impurity 4(Piracetam EP Impurity D)
Piracetam Impurity 4(Piracetam EP Impurity D)
CAS No.53934-76-2
Chemical FormulaC6H9NO3
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 5 structure
5
吡拉西坦杂质5Piracetam Impurity 5
Piracetam Impurity 5
CAS No.1249080-59-8
Chemical FormulaC9H15NO3
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 7 structure
7
吡拉西坦杂质7Piracetam Impurity 7
Piracetam Impurity 7
CAS No.77472-71-0
Chemical FormulaC12H15N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 8 structure
8
吡拉西坦杂质8Piracetam Impurity 8
Piracetam Impurity 8
CAS No.872-50-4
Chemical FormulaC5H9NO
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 9 structure
9
吡拉西坦杂质9Piracetam Impurity 9
Piracetam Impurity 9
CAS No.2454698-45-2
Chemical FormulaC6H12N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 10 structure
10
吡拉西坦杂质10Piracetam Impurity 10
Piracetam Impurity 10
CAS No.89895-19-2
Chemical FormulaC7H13NO
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 11 structure
11
吡拉西坦杂质11Piracetam Impurity 11
Piracetam Impurity 11
CAS No.36821-26-8
Chemical FormulaC7H11NO3
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 12 structure
12
吡拉西坦杂质12Piracetam Impurity 12
Piracetam Impurity 12
CAS No.85909-08-6
Chemical FormulaC9H15NO3
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 15 structure
15
吡拉西坦杂质15Piracetam Impurity 15
Piracetam Impurity 15
CAS No.2144726-13-4
Chemical FormulaC11H18N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 16 structure
16
吡拉西坦杂质16Piracetam Impurity 16
Piracetam Impurity 16
CAS No.94359-90-7
Chemical FormulaC7H12ClNO3
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 17 structure
17
吡拉西坦杂质17Piracetam Impurity 17
Piracetam Impurity 17
CAS No.743379-12-6
Chemical FormulaC8H15NO4
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 19 structure
19
吡拉西坦杂质19Piracetam Impurity 19
Piracetam Impurity 19
CAS No.77191-38-9
Chemical FormulaC7H11NO3
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 20 structure
20
吡拉西坦杂质20Piracetam Impurity 20
Piracetam Impurity 20
CAS No.7060-52-8
Chemical FormulaC8H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 22 structure
22
吡拉西坦杂质22Piracetam Impurity 22
Piracetam Impurity 22
CAS No.1179271-85-2
Chemical FormulaC6H11ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 23 structure
23
吡拉西坦杂质23Piracetam Impurity 23
Piracetam Impurity 23
CAS No.208844-68-2
Chemical FormulaC10H17N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 25 structure
25
吡拉西坦杂质25Piracetam Impurity 25
Piracetam Impurity 25
CAS No.13031-60-2
Chemical FormulaC5H11NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 25 Monomer structure
25
吡拉西坦杂质25 单体Piracetam Impurity 25 Monomer
Piracetam Impurity 25 Monomer
CAS No.3251-07-8
Chemical FormulaC5H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 26 structure
26
吡拉西坦杂质26Piracetam Impurity 26
Piracetam Impurity 26
CAS No.16332-06-2
Chemical FormulaC3H7NO2
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 27 structure
27
吡拉西坦杂质27Piracetam Impurity 27
Piracetam Impurity 27
CAS No.13031-62-4
Chemical FormulaC4H10N2O·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 27 Monomer structure
27
吡拉西坦杂质27 单体Piracetam Impurity 27 Monomer
Piracetam Impurity 27 Monomer
CAS No.3251-08-9
Chemical FormulaC4H10N2O
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 28 structure
28
吡拉西坦杂质28Piracetam Impurity 28
Piracetam Impurity 28
CAS No.2555-04-6
Chemical FormulaC6H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 29 structure
29
吡拉西坦杂质29Piracetam Impurity 29
Piracetam Impurity 29
CAS No.19597-07-0
Chemical FormulaC6H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 30 structure
30
吡拉西坦杂质30Piracetam Impurity 30
Piracetam Impurity 30
CAS No.1121-07-9
Chemical FormulaC5H7NO2
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 31 structure
31
吡拉西坦杂质31Piracetam Impurity 31
Piracetam Impurity 31
CAS No.116-11-0
Chemical FormulaC4H8O
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 32 structure
32
吡拉西坦杂质32Piracetam Impurity 32
Piracetam Impurity 32
CAS No.773832-09-0
Chemical FormulaC7H14N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 33 structure
33
吡拉西坦杂质33Piracetam Impurity 33
Piracetam Impurity 33
CAS No.1178666-33-5
Chemical FormulaC6H13N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 34 structure
34
吡拉西坦杂质34Piracetam Impurity 34
Piracetam Impurity 34
CAS No.5075-92-3
Chemical FormulaC6H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 35 structure
35
吡拉西坦杂质35Piracetam Impurity 35
Piracetam Impurity 35
CAS No.1183628-08-1
Chemical FormulaC6H13N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 36 structure
36
吡拉西坦杂质36Piracetam Impurity 36
Piracetam Impurity 36
CAS No.925-57-5
Chemical FormulaC5H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 37 structure
37
吡拉西坦杂质37Piracetam Impurity 37
Piracetam Impurity 37
CAS No.43170-60-1
Chemical FormulaC6H8ClNO2
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 38 structure
38
吡拉西坦杂质38Piracetam Impurity 38
Piracetam Impurity 38
CAS No.33996-49-5
Chemical FormulaC7H12N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 47 structure
47
吡拉西坦杂质47Piracetam Impurity 47
Piracetam Impurity 47
CAS No.77015-42-0
Chemical FormulaC7H11NO3
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 48 structure
48
吡拉西坦杂质48Piracetam Impurity 48
Piracetam Impurity 48
CAS No.33996-53-1
Chemical FormulaC7H12N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 49 (N-Nitroso Piracetam Impurity 29) structure
49
吡拉西坦杂质49 (N-亚硝基吡拉西坦杂质29)Piracetam Impurity 49 (N-Nitroso Piracetam Impurity 29)
Piracetam Impurity 49 (N-Nitroso Piracetam Impurity 29)
CAS No.476471-28-0
Chemical FormulaC5H8N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 50 structure
50
吡拉西坦杂质50Piracetam Impurity 50
Piracetam Impurity 50
CAS No.2996-58-9
Chemical FormulaC5H9NO
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 52 structure
52
吡拉西坦杂质52Piracetam Impurity 52
Piracetam Impurity 52
CAS No.2555-05-7
Chemical FormulaC5H9NO
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 58 Hydrochloride structure
58
吡拉西坦杂质58 盐酸盐Piracetam Impurity 58 Hydrochloride
Piracetam Impurity 58 Hydrochloride
CAS No.220223-43-8
Chemical FormulaC6H11NO4·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 58 structure
58
吡拉西坦杂质58Piracetam Impurity 58
Piracetam Impurity 58
CAS No.4386-04-3
Chemical FormulaC6H11NO4
Purity>95%询价On request
10mg25mg50mg100mg
Piracetam Impurity 8-d9 structure
8-D9
吡拉西坦杂质8-d9Piracetam Impurity 8-d9
Piracetam Impurity 8-d9
CAS No.185964-60-7
Chemical FormulaC5D9NO
Purity>95%询价On request
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

吡拉西坦 —— 研究文献与合成路线Piracetam — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 吡拉西坦 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Piracetam. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stability-Indicating TLC-Densitometric and HPLC Methods for the Simultaneous Determination of Piracetam and Vincamine in the Presence of Their Degradation Products
    Ahmed AB, Abdelrahman MM, Abdelwahab NS, et al. · Journal of AOAC International · 2016 · 被引 5cited 5
  2. Development and validation of stability indicating chromatographic methods for simultaneous determination of citicoline and piracetam
    Abdelrahman MM, Ahmed AB, Omar MA, et al. · Journal of separation science · 2020 · 被引 3cited 3
  3. Isolation of two Ochrobactrum sp. strains capable of degrading the nootropic drug-Piracetam
    Woźniak-Karczewska M, Čvančarová M, Chrzanowski Ł, et al. · New biotechnology · 2018 · 被引 14cited 14
  4. Simultaneous determination of piracetam and its four impurities by RP-HPLC with UV detection
    Arayne MS, Sultana N, Siddiqui FA, et al. · Journal of chromatographic science · 2010 · 被引 10cited 10
  5. Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products
    El-Houssini OM, Zawilla NH, Mohammad MA · Analytical chemistry insights · 2013 · 被引 8cited 8
  6. Determination of possible impurities in piracetam using FTIR spectroscopy
    Karamancheva I, Staneva T · Journal of pharmaceutical and biomedical analysis · 2000 · 被引 9cited 9

合成与制备工艺专利Synthesis & process patents

  1. Compound preparation of piracetam and its use
    YAN E, YAN YIDONG · 公开号 CN1679611CN1679611 · 2005
  2. Encephalic proteolytic products of compound Piracetam and its preparation
    ZHAO YULONG · 公开号 CN1546063CN1546063 · 2004
  3. Compound piracetam and cerebroprotein hydrolysate medicine preparation and method for preparing the same
    CUI XIAOTING · 公开号 CN1634551CN1634551 · 2005

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

吡拉西坦 杂质谱研究要点Piracetam — impurity profiling notes

下面这些是拿到 吡拉西坦 的 41 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 41 impurity entries for Piracetam, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances